BEIJING, Jan. 20, 2026 /PRNewswire/ -- "The recommendations for the 15th Five-Year Plan are the blueprint for China's economic and social development over the next five years and will unlock a growing ...
Apeiron Biologics is preparing to study an inhaled formulation of its ACE2 receptor decoy APN01. The clinical trial will test whether switching from intravenous to inhaled delivery can expand the ...
The board of FSN Ecommerce Ventures, the parent of beauty ecommerce platform Nykaa, has approved the formulation and implementation of the employee stock option plan 2022 (‘ESOP 2022’) and Stock Unit ...
WATERTOWN, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results